RenalytixAI
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5-7 Cranwood Street, London, Greater Lon...Phone Number
(646) 397-3970Website
www.renalytix.comRevenue
<$5 MillionStock Symbol
RNLXIndustry
About RenalytixAI
Renalytix is dedicated to transforming kidney disease care through its innovative KidneyIntelX technology, which provides data-driven insights to help clinical teams assess patient risk for progressive decline in kidney function, particularly in the early stages of diabetic kidney disease. Their testing methodology enables clinicians to effectively allocate resources and treatments, improving renal and overall health outcomes. The company aims to address the public health crisis of chronic kidney disease, which affects millions globally. Renalytix partners with leading healthcare organizations to enhance kidney health management and has received FDA marketing authorization for its testing solutions.Explore more
SIC Code 87,873NAICS Code 54,541Ticker NASDAQ: RNLXShow moreRenalytixAI Org Chart
Compare Similar Companies to RenalytixAI
Compare insights from companies similar to RenalytixAI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
RenalytixAI
<$5M
51-200
Public
$133M
2018
CC
Cory CoddingtonChief Information Security Officer & Senior Information Risk Owner
RenalytixAI Tech Stack
A closer look at the technologies used by RenalytixAI
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RenalytixAI
Sign Up For FreeTo access detailed company insights
Renalytix is dedicated to transforming kidney disease care through its innovative KidneyIntelX technology, which provides data-driven insights to help clinical teams assess patient risk for progressive decline in kidney function, particularly in the early stages of diabetic kidney disease. Their testing methodology enables clinicians to effectively... Read More